Polypills: Are Miracle Treatments Being Overlooked?

05/06/2017 Tatum Anderson

Cardiovascular diseases (CVD), a group of conditions that can result in heart attacks and strokes, is the world’s number one killer, accounting for one-third of deaths throughout the world, according to research released recently (17 May) by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. Continue reading ->

Coordinated Global Solution Needed To Ensure Universal Vaccine Supply, Speakers Say

19/05/2017 Elise De Geyter

Shortages of vaccines are a worldwide problem with tremendous impact on health, affecting countries of all income groups and regions, speakers said at a recent industry event. Different possible solutions for shortages of vaccines were suggested during the panel discussion. Continue reading ->

G20 Health Ministers Receive Flurry Of Requests Ahead Of Their First-Ever Meeting

18/05/2017 Monika Ermert

Civil society organisations and the Business 20 Dialogue all put their positions on the table before the opening of the first-ever meeting of G20 Health Ministers tomorrow in Berlin, Germany taking place tomorrow. Continue reading ->

New Industry Alliance Aimed At Antimicrobial Resistance

18/05/2017 Catherine Saez

Pharmaceutical industry representatives today announced a new alliance to fight antimicrobial resistance. The announcement came during a meeting of the private sector of the most advanced countries. Continue reading ->

US, EU Diverge On Medical Diagnostic Patents

10/05/2017 Kim Treanor

A recent article in the journal Nature Biotechnology finds that since a key United States Supreme Court decision, the European Union and United States have diverged in their patent filings for medical diagnostics. Continue reading ->

The True Believer: An Interview With New IFPMA Director General Thomas Cueni

08/05/2017 Catherine Saez

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has long been at the centre of global public health policy in Geneva, representing industry from around the world. Now at a critical moment of change in the policymaking machinery, a new leader, Thomas Cueni of Switzerland, has taken over. Intellectual Property Watch recently sat down with him to discuss his views and vision going forward, and discovered his intellectual pragmatism and diverse experience which promise to open an ambitious new era for the association and global health policy. Continue reading ->